Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.18, Iss.2, 2013-04, pp. : 329-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant Chemoradiation Therapy in Patients with Surgically Treated Esophageal Cancer

By Vermund Halvor Pories Walter J. Hillard Jessica Wiley Albert L. Youngblood Robert

Acta Oncologica, Vol. 40, Iss. 5, 2001-09 ,pp. : 558-565

Informa Healthcare

Access to resources Recommend Favorite

Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor

By Tong Daniel

Annals of Surgical Oncology, Vol. 17, Iss. 8, 2010-08 ,pp. : 2184-2192

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1611-1615

Spandidos Publications

Access to resources Recommend Favorite

Expression levels of HER2 and MRP1 are not prognostic factors of longterm survival in 829 patients with esophageal squamous cell carcinoma

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 745-752

Spandidos Publications

Access to resources Recommend Favorite

Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 446-452

Spandidos Publications

Access to resources Recommend Favorite